Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7ZWB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,753
Award facts
- Contract value 100% obligated
- $13,753.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,753.32 to AmerisourceBergen Drug Corp for the supply of Ondansetron Orally Disintegrating Tablets 4 mg in a 30-count quantity. This non-set-aside, competitively awarded contract utilizes firm fixed-price terms with an ultimate completion date of January 20, 2026. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work at that location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle valued through December 31, 2031, which serves as the comprehensive global pharmaceutical supply platform for military healthcare programs worldwide.
Ondansetron is a commonly prescribed antiemetic medication used to prevent nausea and vomiting in military and veteran healthcare settings. As a critical pharmaceutical distributor to federal agencies, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications across multiple therapeutic domains. The DLA Troop Support Medical IDC represents a strategic single-award vehicle enabling efficient fulfillment of pharmaceutical and medical supply requirements for military treatment facilities and federal healthcare systems globally, with capability to deliver specialty medications, vaccines, and related medical commodities essential to military operations and veteran care.
Quick answers
Who was awarded contract SPE2DR26F7ZWB?
SPE2DR26F7ZWB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 19, 2026.
How much is contract SPE2DR26F7ZWB worth?
The government has obligated $13,753 on SPE2DR26F7ZWB.
Is contract SPE2DR26F7ZWB an order under another contract?
Yes. SPE2DR26F7ZWB is a delivery order under SPE2DR25D7066, an indefinite delivery contract.
Was contract SPE2DR26F7ZWB competed?
The extent of competition for SPE2DR26F7ZWB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award